BamSEC and AlphaSense Join Forces
Learn More

Parabilis Medicines Inc. – Material Contracts

NASDAQ: PBLS    
Share price (8/6/26): $35.58    
Market cap (8/6/26): $4.225 billion
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 11 pages Stock Purchase Agreement
12/34/56
EX-10.13
from S-1/A 17 pages Parabilis Medicines, Inc. Executive Severance Plan 1
12/34/56
EX-10.8
from S-1/A 17 pages Employment Agreement
12/34/56
EX-10.7
from S-1/A 4 pages Parabilis Medicines, Inc. Non-Employee Director Compensation Policy
12/34/56
EX-10.6
from S-1/A 4 pages This Senior Executive Cash Incentive Bonus Plan (The “Incentive Plan”) Is Intended to Provide an Incentive for Superior Work and to Motivate Eligible Executives of Parabilis Medicines, Inc. (The “Company”) and Its Subsidiaries Toward Even Higher Achievement and Business Results, to Tie Their Goals and Interests to Those of the Company and Its Stockholders and to Enable the Company to Attract and Retain Highly Qualified Executives. the Incentive Plan Is for the Benefit of Covered Executives (As Defined Below). 2. Covered Executives
12/34/56
EX-10.4
from S-1/A 11 pages Parabilis Medicines, Inc. 2026 Employee Stock Purchase Plan
12/34/56
EX-10.3
from S-1/A 58 pages Parabilis Medicines, Inc. 2026 Stock Option and Incentive Plan
12/34/56
EX-10.14
from S-1/A 8 pages Parabilis Medicines, Inc. Compensation Recovery Policy Adopted as of , 2026, Subject to Effectiveness of the Company’s Registration Statement on Form S-1 for Its Initial Public Offering
12/34/56
EX-10.13
from S-1/A 16 pages Parabilis Medicines, Inc. Executive Severance Plan 1
12/34/56
EX-10.12
from S-1/A 72 pages License and Collaboration Agreement by and Between Parabilis Medicines, Inc. and Regeneron Pharmaceuticals, Inc. Dated as of May 15, 2026
12/34/56
EX-10.7
from S-1/A 4 pages Parabilis Medicines, Inc. Non-Employee Director Compensation Policy
12/34/56
EX-10.6
from S-1/A 4 pages This Senior Executive Cash Incentive Bonus Plan (The “Incentive Plan”) Is Intended to Provide an Incentive for Superior Work and to Motivate Eligible Executives of Parabilis Medicines, Inc. (The “Company”) and Its Subsidiaries Toward Even Higher Achievement and Business Results, to Tie Their Goals and Interests to Those of the Company and Its Stockholders and to Enable the Company to Attract and Retain Highly Qualified Executives. the Incentive Plan Is for the Benefit of Covered Executives (As Defined Below). 2. Covered Executives
12/34/56
EX-10.5
from S-1/A 35 pages Parabilis Medicines, Inc. Indemnification Agreement
12/34/56
EX-10.4
from S-1/A 11 pages Parabilis Medicines, Inc. 2026 Employee Stock Purchase Plan
12/34/56
EX-10.3
from S-1/A 61 pages Parabilis Medicines, Inc. 2026 Stock Option and Incentive Plan
12/34/56
EX-10.11
from S-1 76 pages Lease of Premises at Cambridge Discovery Park Cambridge, Massachusetts From 400 Discovery Park, LLC to Fog Pharmaceuticals, Inc. April 22, 2019
12/34/56
EX-10.9
from S-1 34 pages License Agreement
12/34/56
EX-10.2
from S-1 54 pages Parabilis Medicines, Inc. 2026 Stock Option and Grant Plan
12/34/56
EX-10.1
from S-1 27 pages Parabilis Medicines, Inc. 2016 Employee, Director and Consultant Equity Incentive Plan
12/34/56
EX-10.11
from DRS 91 pages Lease of Premises at Cambridge Discovery Park Cambridge, Massachusetts From 400 Discovery Park, LLC to Fog Pharmaceuticals, Inc. April 22, 2019
12/34/56